Prevalence of Anti-Group B Streptococcal Type III Capsular IgG Antibodies in the United Kingdom and an Analysis of Their Specific IgG Subclasses
- 1 October 1990
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 162 (4) , 883-887
- https://doi.org/10.1093/infdis/162.4.883
Abstract
Neonatal infection due to group B streptococcus (GBS) has a higher incidence in the USA than in the United Kingdom. A British population was investigated to ascertain the proportion of women who have protective anti-GBS type III IgG levels. Thirty-one (34%) of 90 pregnant women, 10 (43%) of 23 nonpregnant women, and 5 (50%) of 10 mothers of healthy colonized infants had anti-type III IgG .gtoreq.2 .mu.g/ml. Of 19 mothers who had infants infected with GBS type III, 17 (89%) had low specific IgG levels; of the other 2, the infants themselves had low IgG levels. The proportion of women in the UK with protective antibody levels is higher than in the USA. Sera(12) were assayed for anti-type III IgG isotypes: all contained IgG2, 6 had detectable IgG1, and 1 had IgG4.This publication has 3 references indexed in Scilit:
- Immunization of Pregnant Women with a Polysaccharide Vaccine of Group B StreptococcusNew England Journal of Medicine, 1988
- Concentrations of antibodies in paired maternal and infant sera: Relationship to IgG subclassThe Journal of Pediatrics, 1987
- Immunogenicity of polysaccharides from type III, group B Streptococcus.Journal of Clinical Investigation, 1978